Agenus reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
AstraZeneca AZN:LN 27146M 1659M
Bristol Myers Squibb BMY:US $ 37107M 343M
Celldex Therapeutics CLDX:US $ 0M 0M
Chemocentryx CCXI:US $ 4M 0.55M
CSL CSL:AU $ 5.2B 136.2M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Eli Lilly And LLY:US $ 14692M 460.9M
Genocea Biosciences GNCA:US $ 2.95M 1.2M
Glaxosmithkline GSK:US $ 18784M 10442M
GlaxoSmithKline GSK:LN 18784M 10442M
Jiangsu Hengrui Me. 600276:CH CH 143.75M 7.84M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Macrogenics MGNX:US $ 0 0
Merck MRK:GR € 9385M 1099M
Northwest Biotherapeutics NWBO:US 16.16M 8.99M
Novartis NOVN:VX SF 23784M 589M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Veracyte VCYT:US $ 0.6M 0M
YTE INCY:US $ 31.16M 0.23M